HK Stock Market Move | CHINAGOLDINTL (02099) rose nearly 4% and will announce third-quarter performance next week. Longshan Haokou gold mine production gradually recovering.
China Gold International Resources (02099) rose nearly 4%, as of the time of writing, it was up 2.87% at 132.4 Hong Kong dollars, with a transaction volume of 46.5265 million Hong Kong dollars.
CHINAGOLDINTL (02099) rose nearly 4%, as of press time, up 2.87% to 132.4 Hong Kong dollars, with a turnover of 46.5265 million Hong Kong dollars.
On the news front, CHINAGOLDINTL announced that the company will hold a board meeting on Thursday, November 13, 2025 (Beijing time) to review and approve the third quarter results of the company and its subsidiaries for the nine months ended September 30, 2025.
Minsheng Securities pointed out that the company owns two high-quality mines, Changshan Hao Gold Mine and Jamadu Metal Mine. The company operated steadily and profitability steadily increased before 2023. Due to the tailings dam incident in 2023, the production capacity was reduced from 50,000 tons/day to 34,000 tons/day. In the future, it is expected to benefit from the three-step plan of restoring production capacity to over 50,000 tons/day through the construction of the third tailings dam, expansion of mining permits, and exploration and development in the surrounding areas. It is expected to issue a new mining report by April 2026.
Related Articles

SHINEWAY PHARM (02877) had a revenue of 2.415 billion RMB in the first three quarters, a decrease of 16.3% year-on-year.

FIRST PACIFIC (00142) has completed the proposed demerger of MAYNILAD WATER SERVICES, INC. and will independently list on the Philippine Stock Exchange.

BOAN BIOTECH (06955): Two types of Dexu Monoclonal Antibody Injections have been accepted for market approval in the United Kingdom.
SHINEWAY PHARM (02877) had a revenue of 2.415 billion RMB in the first three quarters, a decrease of 16.3% year-on-year.

FIRST PACIFIC (00142) has completed the proposed demerger of MAYNILAD WATER SERVICES, INC. and will independently list on the Philippine Stock Exchange.

BOAN BIOTECH (06955): Two types of Dexu Monoclonal Antibody Injections have been accepted for market approval in the United Kingdom.

RECOMMEND

SERES Faces Market Test in Hong Kong: Shares Open Below Issue Price Despite HK$220 Billion Market Valuation
06/11/2025

Copper Prices Surge While Former “Copper King” Who Outpaced Huawei and Tencent Falls into Decline
06/11/2025

National Energy Administration Reports New-Type Energy Storage Capacity Exceeds 100 Million Kilowatts by End‑September
06/11/2025


